M

Mingyue Optical Lens Co Ltd
SZSE:301101

Watchlist Manager
Mingyue Optical Lens Co Ltd
SZSE:301101
Watchlist
Price: 38.47 CNY -0.21%
Market Cap: 7.8B CNY
Have any thoughts about
Mingyue Optical Lens Co Ltd?
Write Note

Mingyue Optical Lens Co Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mingyue Optical Lens Co Ltd
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
M
Mingyue Optical Lens Co Ltd
SZSE:301101
Cash from Investing Activities
-ÂĄ369.4m
CAGR 3-Years
-140%
CAGR 5-Years
-70%
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Cash from Investing Activities
-ÂĄ1.6B
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Cash from Investing Activities
ÂĄ32.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autobio Diagnostics Co Ltd
SSE:603658
Cash from Investing Activities
-ÂĄ302.8m
CAGR 3-Years
55%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Cash from Investing Activities
ÂĄ1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Cash from Investing Activities
-ÂĄ290.7m
CAGR 3-Years
51%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
No Stocks Found

Mingyue Optical Lens Co Ltd
Glance View

Market Cap
7.7B CNY
Industry
Health Care

In the dynamic landscape of the optical industry, Mingyue Optical Lens Co Ltd stands out as an influential player, weaving technology with craftsmanship to redefine vision solutions. Established in 1997, the company has steadily expanded its footprint across China and beyond, driven by a commitment to innovation and quality. Mingyue specializes in the research, development, and manufacturing of optical lenses, utilizing state-of-the-art facilities to produce a wide range of products, from single vision and bifocal lenses to advanced progressive and blue light-blocking lenses. The company's strength lies not just in its cutting-edge production technology but in its deep understanding of consumer needs, which allows it to create lenses that offer clarity, comfort, and protection. By investing in R&D, Mingyue stays ahead in the competitive eyewear market and continually enhances its product portfolio to meet the evolving demands of both opticians and consumers. At the heart of Mingyue Optical's business model is a vertically integrated approach that ensures quality control and cost efficiency from raw material sourcing to final product distribution. This approach enables the company to maintain pricing competitiveness while upholding strict quality standards, fostering trust and loyalty among its customer base. Mingyue's revenue streams primarily flow from the wholesale distribution of its lenses to optical retailers, eye care professionals, and direct partnerships with eyewear brands. Additionally, the company leverages its strong distribution network and strategic partnerships to penetrate international markets, contributing significantly to its growth and profitability. By constantly aligning its operations with market trends and consumer preferences, Mingyue Optical continues to thrive, positioning itself as a significant force in the global optics industry.

Intrinsic Value
33.92 CNY
Overvaluation 12%
Intrinsic Value
Price
M

See Also

What is Mingyue Optical Lens Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-369.4m CNY

Based on the financial report for Dec 31, 2023, Mingyue Optical Lens Co Ltd's Cash from Investing Activities amounts to -369.4m CNY.

What is Mingyue Optical Lens Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-70%

Over the last year, the Cash from Investing Activities growth was -245%. The average annual Cash from Investing Activities growth rates for Mingyue Optical Lens Co Ltd have been -140% over the past three years , -70% over the past five years .

Back to Top